dalia raslan

dalia raslan

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 September 2023 in Molecules
Verified
Journal Article
Open access
PDF file
AGAdel S. Girgis
Adel S. Girgis
Siva S. PandaSiva S. Panda
Siva S. Panda
BKBenson Kariuki
Benson Kariuki
MBMohamed Bekheit
Mohamed Bekheit
Reham BarghashReham Barghash
Reham Barghash
DRdalia raslan
dalia raslan
The COVID-19 pandemic has posed a significant threat to society in recent times, endangering human health, life, and economic well-being. The disease quickly spreads due to the highly infectious SARS-CoV-2 virus, which has undergone numerous mutations. Despite intense research efforts by the scientific community since its emergence in 2019, no effective therapeutics have been discovered yet. While some repurposed drugs have been used to control the global outbreak and save lives, none have proven universally effective, particularly for severely infected patients. Although the spread of the disease is generally under control, anti-SARS-CoV-2 agents are still needed to combat current and future infections. This study reviews some of the most promising repurposed drugs containing indolyl heterocycle, which is an essential scaffold of many alkaloids with diverse bio-properties in various biological fields. The study also discusses natural and synthetic indole-containing compounds with anti-SARS-CoV-2 properties and computer-aided drug design (in silico studies) for optimizing anti-SARS-CoV-2 hits/leads.

8 June 2020 in RSC Advances
Verified
Journal Article
Open access
PDF file
MYM. Adel Youssef
M. Adel Youssef
Siva S. PandaSiva S. Panda
Siva S. Panda
RERiham A. El-Shiekh
Riham A. El-Shiekh
ESElSayed M. Shalaby
ElSayed M. Shalaby
DRdalia raslan
dalia raslan
AGAdel S. Girgis
Adel S. Girgis
A set of dispiro[indoline-3,2′-pyrrolidine-3′,3′′-pyrrolidines] 8a–l was regioselectively synthesized utilizing multi-component azomethine cycloaddition reaction of 3-(arylmethylidene)pyrrolidine-2,5-diones 5a–e, isatins 6a–c and sarcosine 7. Single crystal X-ray studies of 8c add conclusive support for the structure. Compounds 8e and 8g reveal cholinesterase inhibitory properties with promising efficacy against both AChE and BChE and were found to be more selective towards AChE than BChE as indicted by the selectivity index like Donepezil (a clinically used cholinesterase inhibitory drug). Molecular modeling studies assist in understanding the bio-observations and identifying the responsible parameters behind biological properties.

19 February 2025 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
AGAdel S. Girgis
Adel S. Girgis
Yujun ZhaoYujun Zhao
Yujun Zhao
ANAngel Kiggundu Nkosi
Angel Kiggundu Nkosi
NINasser Ismail
Nasser Ismail
MBMohamed Bekheit
Mohamed Bekheit
Siva S. PandaSiva S. Panda
Siva S. Panda
The p53, often referred to as the “guardian of the genome”, is a well-established tumor-suppressor protein that plays a critical role in regulating the cell cycle, DNA repair, differentiation, and apoptosis, with its activity primarily modulated by the MDM2 protein (murine double minute 2, also known as HDM2 in humans). Disrupting the protein-protein interaction between p53 and MDM2 represents a promising therapeutic strategy for developing anticancer agents. Recent studies have shown that several spirooxindole-containing compounds exhibit significant antitumor properties, primarily by inhibiting the p53–MDM2 interaction. This review provides an overview of structure-based spirooxindoles that could have therapeutic potential. It highlights findings from the past decade concerning their antiproliferative properties and implications for interfering with the p53–MDM2 interaction. The discussion includes various analogs of spirooxindoles as promising candidates for optimizing leads in drug discovery programs aimed at developing novel and clinically effective agents.

14 February 2024 in RSC Advances
Verified
Journal Article
Open access
PDF file
DRdalia raslan
dalia raslan
MYM. Adel Youssef
M. Adel Youssef
MBMohamed Bekheit
Mohamed Bekheit
AHAhmed Ragab Hamed
Ahmed Ragab Hamed
AGAdel S. Girgis
Adel S. Girgis
VEGF, an important category of tyrosine kinases, and its receptors (VEGFR) are hyper-activated in different cancers. The recently reported indolyl analogs with potential antineoplastic and VEGFR inhibitory properties are highlighted.

27 October 2022 in RSC Advances
Verified
Journal Article
Open access
PDF file
AGAdel S. Girgis
Adel S. Girgis
PDPadraig D'Arcy
Padraig D'Arcy
DRdalia raslan
dalia raslan
MBMohamed Bekheit
Mohamed Bekheit
3,5-Diyliden-4-piperidone scaffold are considered as curcumin mimic exhibiting diverse bio-properties.

9 August 2023 in Preprints.org
Verified
Preprint
Open access
PDF file
AGAdel S. Girgis
Adel S. Girgis
Siva S. PandaSiva S. Panda
Siva S. Panda
BKBenson Kariuki
Benson Kariuki
MBMohamed Bekheit
Mohamed Bekheit
Reham BarghashReham Barghash
Reham Barghash
DRdalia raslan
dalia raslan
The COVID-19 pandemic has posed a significant threat to society in recent times, endangering human health, life, and economic well-being. The disease spreads quickly due to the highly infectious SARS-CoV-2 virus, which has undergone numerous mutations. Despite intense research efforts by the scientific community since its emergence in 2019, no effective therapeutics have been discovered yet. While some repurposed drugs have been used to control the global outbreak and save lives, none have proven universally effective, particularly for severely infected patients. Although the spread of the disease is generally under control, anti-SARS-CoV-2 agents are still needed to combat current and future infections. This study reviews some of the most promising repurposed drugs containing indolyl heterocycle, which is an essential scaffold of many alkaloids with diverse bio-properties in various biological fields. The study also discusses natural and synthetic indole-containing compounds with anti-SARS-CoV-2 properties, as well as computer-aided drug design (in-silico studies) for optimizing anti-SARS-CoV-2 hits/leads.